Fidelity Disruptive Medicine Fund - Class F (FRXNX) Forecast
See the Price Targets and Ratings of:
FRXNX Analyst Rating
Moderate Buy
67ConsensusRatings
47Buy19Hold1Sell
Based on the Wall Street analyst consensus for 67 of FRXNX’s holdings.
FRXNX Analyst Price Target
Average Price Target
$14.28▲(21.90% Upside)
Based on Wall Street analyst 12-month price targets for 67 of Fidelity Disruptive Medicine Fund - Class F’s holdings in the last 3 months. The average price target is $14.28 with a high forecast of $17.39 and a low forecast of $11.40. The average price target represents a 21.90% change from the last price of $11.71.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$17.39
Average$14.28
Low$11.40
Past 12 Months12 Month Forecast$10$12$14$16$18Feb2026May2026Aug2026Nov2026Nov2027
What is FRXNX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 67 of FRXNX’s holdings, Fidelity Disruptive Medicine Fund - Class F’s 12-month average price target is $14.28.
What is FRXNX’s upside potential, based on the analysts’ average price target?
FRXNX’s average price target of $14.28 represents a 21.90% upside from its last price of $11.71.
Is FRXNX a Buy, Sell or Hold?
Fidelity Disruptive Medicine Fund - Class F has a consensus rating of Moderate Buy, based on the analyst consensus for 67 of FRXNX’s holdings: 47 rated Buy, 19 rated Hold and 1 rated Sell.
What is Fidelity Disruptive Medicine Fund - Class F’s price target?
The average price target for Fidelity Disruptive Medicine Fund - Class F is $14.28, based on Wall Street analyst 12-month price targets for 67 of FRXNX’s holdings, issued in the past 3 months. The highest price target is $17.39 and the lowest is $11.40. The average price target represents a 21.90% increase from the last price of $11.71.
How can I buy shares of FRXNX?
You can buy shares of FRXNX through a brokerage account. Compare brokers on our Best Online Brokers page.